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Prostate-Specific Antigen Screening According to Health Professional Counseling
and Age in the United State
Seth A. Otto, Ray M. Merrill, Department of Public Health, College of Life Sciences, Brigham Young University

INTRODUCTION
• Prostate cancer is the most common cancer
among men in the United States.
• It accounted for approximately 25.6% of all
cancers in the United States in 2021.
• Because prostate cancer is a slow-growing
tumor, men generally die with it than from it.
• Prostate cancer screening has been
controversial due to the potential for over
diagnosis.
• The most common type of prostate cancer
screening remains measuring
prostate-specific antigen (PSA) protein in the
blood.
• A high PSA score and subsequent treatment
can save life, but also is also invasive and can
cause sexual complications and urinary issues.
• Routine PSA screening is recommended by
the US Preventive Services Task Force for men
aged 55-69, but not thereafter except in
certain unusual circumstances.
• After a discussion with their doctor about the
harms and benefits of PSA testing, men at risk
should decide whether they desire to
undergo screening or not.

PURPOSE
To determine the prevalence of PSA testing
in men according to age, reasons for
undergoing testing, and whether a discussion
about harms and benefits took place with a
doctor prior to testing.

METHODS
Data for the study was taken from the Behavioral
Risk Factor Surveillance System (BRFSS). The BRFSS
uses a random digit dialing technique to
administer telephone surveys across the United
States. Analyses were restricted to men aged 40 or
older who had been screened for PSA.
Frequencies and percentages were calculated for
prevalence data. Multiple logistic regression was
used to calculate adjusted odds ratios. Other
variables such as race/ethnicity, marital status,
education level, income, family history, health
insurance status, and age were also included in
the study.

Figure 1. PSA test in the past two years according to previous
recommendation for the test from a health professional and age.

CONCLUSION
Figure 2. PSA test in the past two years according to age and
race/ethnicity.

RESULTS
• About 32.0% of respondents had a PSA test
within the past two years.
• The prevalence of PSA testing was highest in
non-Hispanic whites and African-Americans.
• Undergoing prostate cancer screening was most
commonly performed as a routine examination.
• About 42.4% of the participants had a
conversation with a health professional about the
harms and benefits of a PSA test. Those who had
this discussion (about both advantages and
disadvantages) were more likely to have a test.
• PSA testing was most common among men who
were married, had higher education, had higher
income, smoked less, were overweight or obese,
had a family history of prostate cancer, and were
currently enrolled in a health insurance plan.
• A high percentage of men had the PSA test who
were 70 years or older

• PSA screening for men is highest in the
70-79 years age group, which is contrary
to the recommendations of the US
Preventive Services Task Force.
• There is a significant need for informed
decision-making in men considering
having a PSA test.
• Although the majority of men had a
discussion about the harms and/or
benefits of a PSA test with a health
professional, these discussions need more
balance.
• There are many disparities in
recommendations and discussions among
different racial/ethnic groups.
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